Thieme-Verlagsdatenbank contains bibliographic data and abstracts (approx. 63 %) belonging to documents from approx. 180 medical and scientific journals published Thieme-Verlag since 1981. Database documents are all linked with the corresponding original full texts as PDF, available for a fee. A further specialty is the link of the full texts plus the corresponding publication information from other bibliographic databases like MEDLINE or EMBASE. DIMDI provides the Thieme-Verlagsdatenbank in cooperation with the German National Library of Medicine (ZB MED).
| Subject Coverage | Medicine and related fields |
|---|---|
| Type | Literature database |
| Language | English |
| Sources | Approx. 180 journals from Georg Thieme Verlag |
| Superbases | There are predefined databases groups (superbase) for several subjects. The database Thieme-Verlagsdatenbank is part of the following superbases: |
| File Size | 93,787 (Status 06/2011) |
|---|---|
| File Data |
You will find the number of database records in the current update status. |
| Update Cycle | Daily |
Standing orders (SDI) are possible for Premium customers.
The following document sections are considered with the free text search (FT):
Abstract (AB)
Document type (DT)
Title (TI)
Uncontrolled Terms (UT)
Search language(s) in the basic index:
English/German
Explanation:
D = DISPLAY F = FIND S = SHOW
(F): field is searchable
only via basic index
| Command | Field Name | Examples | Notes |
|---|---|---|---|
| (F) S | AB Abstract | F mistletoe extract/AB | In approx. 70 % of the documents. |
| (F) | ABG Abstract German | F analyse?/ABG | Searchable as of 01/2006. Display with S F=AB. |
| D F S | AI Abstract Indicator | F AI=abstract online | Search for citations with an abstract online. |
| D F S | AU Author | F AU= matthes h | End-masking required, if first name is not known. |
| S | AUL Author long | AUL: Matthes Harald | If known first names of authors written in full. |
| D F S | CS Corporate Source | F CS=charite berlin | |
| D F S | DT Dokument Type | F DT=editorial | Editorial, letter and news available. |
| D DT=? | Lists the available document types. | ||
| D F S | DOI Digital Object Identifier | D DOI=? F DOI="10.1055/s-2002-32772" |
Must be set in quotation marks. A DOI is a unique and persistent identification code for digital objects. |
| D F S | ISS Issue | F ISS=7 | Part of SO. |
| D F S | ISSN International Standard Serial Number | F ISSN=1439-9903 | Hyphen recommended. |
| D F S | EISSN Electronic International Standard Serial Number | F EISSN=1098-8785 EISSN: 1098-8785 /20081007/ |
Shown is also the electronic publication date in this field. See also field PDE. Also searchable in the field ISSN. |
| D F S | JT Journal Title | F JT="sleep breath" D JT= sleep? |
Part of SO. Journal Title often abbreviated. Quotes required. |
| D F S | LA Language | F ... AND LA=germ | Language of the document. |
| D F S | ND Document Number | F ND=TVs-2002-32772 | Unique Number of Document. Publication Year of Volume integrated. |
| D F S | OTI Original title | F obstkernsaspiration/OTI | In German, French, English available. |
| D F S | PAGE Page | F PAGE=12-14 | Part of SO. |
| D F S | PD Publication Date | F PD=200207 F PD=2002? |
Part of SO, different formats. |
| D F S | PDE Publication Date Electronic | F PDE=20080218 F PDE=2008? |
Publication Date of the electronic version of a journal. Shown as part of the field EISSN. |
| D F | PPS PreProcessed Searches | D PPS=? | Shows all subjects for whose precasted search profiles are available (see appendix). |
| F ... AND PPS=human | Search for all documents relating (also) to humans. | ||
| D F S | PU Publisher | F PU= thieme PU: Georg Thieme Verlag Stuttgart, NewYork |
Here always Georg Thieme Verlag Stuttgart, New York. |
| D F S | PY Publication Year | F PY=2002 | Part of the Source-field (SO). |
| S | SO Source | SO: Suchttherapie; Vol. 3 (Suppl. 1) p. S78-S82; 200207 | Contains JT, VOL, ISS, PAGE, PD. |
| (F) S | TI Title | F alternative strateg?/TI | All titles in English, partly original titles in German and French available. |
| D F S | UT Uncontrolled Terms | F UT=infection F infection/UT D UT=infection |
Searchable as of 01/2006. Available in German and English. Not in each document available. |
| D F S | VOL Volume | F VOL= 23 | Part of SO. |
By means of the commands SHOW (S) / MAIL / SDI.
Corresponding to the copyright rules use the parameter USE=DLOAD if necessary. You may ask for all data fields, single data fields, or sets of data fields. If the output fields are not specified explicitly, the standard field set (F=STD) is used in all output commands.
Output field sets:
| Command | Field Set | Associated Datafields |
|---|---|---|
| F=STD | Standard | As ALL |
| F=ALL | all fields | ND, AU, TI, SO, DOI, PU, LA, ISSN, EISSN, CS, DT, UT, AB |
| F=BIB | bibliographic fields | ND, AU, TI, SO, DOI, PU, LA, ISSN, EISSN, CS, DT |
Database selection in DIMDI ClassicSearch: SBAS TV01
Subject: Hepatitis and drug substitution
Profile table:
| Parameter | Counter | Number of Hits | Query |
|---|---|---|---|
| C= | 1 | 89650 | TV01 |
| S= | 2 | 644 | HEPATIT? |
| 3 | 638 | drug addict? OR heroin? OR drogen? OR methadon? OR opiat? OR opioid? |
|
| 4 | 1564 | maintenan? OR substitut? OR entzug? OR withdrawal? OR detoxific? |
|
| 5 | 20 | 2 AND 3 AND 4 |
DIMDI: Thieme-Verlagsdatenbank (TV01) © Thieme-Verlag
| ND: | TVs-2006-957209 |
| AU: | Deibler P; Haasen C; Reimer J |
| TI: | Treatment of chronic hepatitis C within a heroine-assisted
treatment program Therapie der chronischen Hepatitis C im Rahmen einer heroingestützten Behandlung |
| SO: | Dtsch med Wochenschr; VOL: 131 (50); p. 2835-2837 /200612/ |
| DOI: | 10.1055/s-2006-957209 |
| PU: | Georg Thieme Verlag Stuttgart, New York |
| LA: | German |
| ISSN: | 0012-0472 |
| CS: | Zentralinstitut für Seelische Gesundheit, Klinik für Psychosomatik und Psychotherapeutische Medizin |
| UT: | Hepatitis C; heroine-assisted treatment; injection drug users; Hepatitis C; heroingestützte Behandlung; intravenös Drogenabhängige |
| AB: | HISTORY AND FINDINGS: A 37-year-old man with a 19-years history
of injection drug use (IDU) who had acquired a chronic hepatitis C
virus (HCV-) infection 9 years ago, entered the German clinical
study on heroine assisted treatment ("Modellprojekt zur
heroingestützten Behandlung Opiatabhängiger"). Before study onset
he received buprenorphine maintainance treatment, while at the same
time engaging in illicit IDU (heroine, cocaine). He lived in a
caravan and was on social welfare. INVESTIGATIONS: PCR revealed a
genotype 2 and an HCV-viral load of 310 000 IU/ml. Liver biopsy
showed a moderate chronic active hepatitis and a mild portal
fibrosis without signs of liver cirrhosis. DIAGNOSIS, TREATMENT AND
COURSE: Within the heroine-assisted treatment program the patient
injected heroine under medical supervision several times a day and
attended the standardized psychosocial program that comprised an
intensive education on HCV-infection. Within a period of ten months
of physical and social stabilization he managed to stop illicit
drug use, found stable housing and started to work. We then
initiated treatment of HCV-infection. Subcutaneous pegylated
interferon alpha-2a, peroral ribavirin and intravenous heroine were
administered as directly observed therapy. Based on the close
mashed care of the heroine assisted treatment setting, side effects
were well controllable and reversible after the end of antiviral
therapy. A sustained response was obtained. CONCLUSION: After
careful indication, heroine-assisted treatment with particularly
intensive medical and psychological care can offer appropriate
conditions for a save and successful treatment of hepatitis C as
well as for a sustained result. ANAMNESE UND KLINISCHER BEFUND: Ein 37-jähriger, seit 19 Jahren intravenös drogenabhängiger Patient mit seit 9 Jahren bekannter chronischer Hepatitis-C-Virus- (HCV-) Infektion wurde in das Modellprojekt zur heroingestützten Behandlung Opiatabhängiger aufgenommen. Er befand sich in einer Substitutionsbehandlung mit Buprenorphin, konsumierte regelmäßig Heroin und Kokain, lebte in einem Wohnwagen und erhielt Sozialhilfe. UNTERSUCHUNGEN: Die PCR erbrachte eine HCV-Viruslast von 310 000 IU/ml sowie einen Genotyp 2. Die Leberbiopsie zeigte eine mäßige, chronisch aktive Hepatitis mit leichter portaler Fibrose ohne zirrhotischen Umbau. DIAGNOSE, THERAPIE UND VERLAUF: Im Rahmen der heroingestützten Behandlung injizierte der Patient mehrfach am Tag unter ärztlicher Aufsicht Heroin und nahm die standardisierte psychosoziale Begleitung wahr, die eine intensive Schulung bezüglich der HCV-Infektion beinhaltete. Nach einer 10monatigen Phase gesundheitlicher und sozialer Stabilisierung, in der es ihm gelang, den Beikonsum einzustellen und eine Wohnung sowie Arbeit zu finden, wurde die antivirale Behandlung der chronischen HCV-Infektion eingeleitet. Pegyliertes Interferon alpha-2a wurde subkutan injiziert, Ribavirin peroral verabreicht. Die Medikamenteneinnahme erfolgte zusammen mit den intravenösen Heroininjektionen unter Sicht. Die Nebenwirkungen der antiviralen Medikamente waren im Rahmen der heroingestützten Behandlung gut beherrschbar und nach Therapieende reversibel. Es gelang eine anhaltende Viruselimination. FOLGERUNG: Eine heroingestützte Behandlung kann durch intensive Betreuung und häufige Arztkontakte nach sorgfältiger Indikationsstellung eine gute Voraussetzung für eine sichere, erfolgreiche und nachhaltig wirksame Behandlung der chronischen Hepatitis C bieten. |
Output format: SHOW F=ALL
Rüdigerstraße 14
70469 Stuttgart
Germany
Phone: +49 711 8931-0
Fax: +49 711 8931-298
List of the PreProcessed Searches
For the following subjects preprocessed searches are available:
AIDS
ANIMAL
CANCER
HUMAN